Projects funded by the NCN
Inhibitors of anti-apoptotic proteins from the BCL-2 family as agents enhancing BRAFV600E inhibition in melanoma cells.
2016/23/D/NZ7/03904
Keywords:
apoptosis BCL-2 proteins BH3 mimetics BRAF melanoma targeted therapy
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi, Międzywydziałowa Katedra Chemii i Biochemii Medycznej
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: SONATA 12 - announced on 2016-09-15
Amount awarded: 748 670 PLN
Project start date (Y-m-d): 2017-08-11
Project end date (Y-m-d): 2021-02-10
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.